Shortest paths ranking methodology to identify alterations in PPI networks of complex diseases

Complex diseases are commonly caused by a combination of genetic alterations in several genes, which lead to abnormal propagation of signals along biological pathways. Assuming that DNA alterations can modulate, through biological pathways, differentially expressed genes, it is important to reveal and analyze gene interaction networks, as well as to identify their key players, in order to contribute to the understanding of such mechanisms occurring in complex diseases. In this way, integration of several data sources is an increasingly common trend since it has shown promise on revealing intricate molecular interactions present in complex diseases. Particularly in this context, many studies show the importance of methods that integrate data from genetic alterations, transcriptome and protein-protein interaction (PPI). Our hypothesis is that, starting with source and target genes set, expression data (in two different conditions: control and disease) and interactome data, our method integrates these data and constructs the network that has the genes/interactions more related to the corresponding complex disease. We proposed a methodology that determines potentially relevant genes and links (interactions) related to complex diseases in biological pathways by integrating association studies, gene expression data and human interactome (PPI). Our method consists in selecting the shortest paths between source genes and target genes that have the highest sum of absolute correlation values among the intermediate and target genes. Then, the intermediate genes are ranked by their frequencies in the selected paths. This is done for both expression profiles (control and disease) generating two networks. Next, the relative ranks of the genes/links in both networks are compared and those with the highest alterations are prioritized to compose the resulting alteration network. To validate our method, we adopted the schizophrenia as a case study and showed that the method is promising in recovering genes known to be related to such disease.

[1]  E. Lambe,et al.  Schizophrenia susceptibility pathway neuregulin 1–ErbB4 suppresses Src upregulation of NMDA receptors , 2011, Nature Medicine.

[2]  P. Jia,et al.  SZGR: a comprehensive schizophrenia gene resource , 2009, Molecular Psychiatry.

[3]  Chang-Gyu Hahn,et al.  A Src link in schizophrenia , 2011, Nature Medicine.

[4]  Trey Ideker,et al.  Cytoscape 2.8: new features for data integration and network visualization , 2010, Bioinform..

[5]  A. Barabasi,et al.  Network medicine : a network-based approach to human disease , 2010 .

[6]  E. Schadt Molecular networks as sensors and drivers of common human diseases , 2009, Nature.

[7]  Teresa M. Przytycka,et al.  Identifying Causal Genes and Dysregulated Pathways in Complex Diseases , 2011, PLoS Comput. Biol..

[8]  Yonina C. Eldar,et al.  eQED: an efficient method for interpreting eQTL associations using protein networks , 2008, Molecular systems biology.

[9]  Jing Chen,et al.  Disease candidate gene identification and prioritization using protein interaction networks , 2009, BMC Bioinformatics.

[10]  M. Salter,et al.  Dysregulated Src upregulation of NMDA receptor activity: a common link in chronic pain and schizophrenia , 2012, The FEBS journal.

[11]  Wenjun Gao,et al.  Dopamine D1 receptor-mediated NMDA receptor insertion depends on Fyn but not Src kinase pathway in prefrontal cortical neurons , 2010, Molecular Brain.

[12]  P. Robinson,et al.  Walking the interactome for prioritization of candidate disease genes. , 2008, American journal of human genetics.